🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study assessed the safety, tolerability, and efficacy of LCZ696 in sev...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-07
Trial ID
NCT01646671
The purpose of this 12-week active controlled trial is to evaluate the safe...
Status
Completed
Location
Sites in USA
Start Date
2007-01
Trial ID
NCT00433836
The purpose of this study is to evaluate the blood pressure lowering effect...
Status
Completed
Location
Novartis Pharmaceuticals Corp
Start Date
2006-06
Trial ID
NCT00350168
Treatments Being Tested
Heart failure is the most common cause of death of patients on chronic hemo...
Status
Completed
Location
University Clinical Hospital Mostar
Start Date
2026-01-30
Trial ID
NCT07417215
Treatments Being Tested
The purpose of this randomized, actively controlled, double-blind study wit...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-12-20
Trial ID
NCT02900378
Studies have demonstrated that the early initiation of ACEI/ARB to patients...
Status
Unknown
Location
Mengmei Li
Start Date
2021-10
Trial ID
NCT05060588
Treatments Being Tested
The purpose of this study is to compare the effect of valsartan and perindo...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2014-11
Trial ID
NCT02299310
Treatments Being Tested
The concept of improving arterial wall characteristics by treatment with a ...
Status
Completed
Location
Department of Vascular Diseases, University Medical Centre Ljubljana
Start Date
2012-11
Trial ID
NCT03309618
Treatments Being Tested
Nephropathy of type 2 diabetes is the leading cause of end stage renal dise...
Status
Completed
Location
Hospital "Azienda Ospedaliera Ospedali Riuniti di Bergamo" - Unit of Diabetology
Start Date
2007-05
Trial ID
NCT00494715
Treatments Being Tested
A randomized, open-label, single dosing, two-way crossover clinical trial t...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2014-05
Trial ID
NCT02088008
Treatments Being Tested